Top

Strahlentherapie und Onkologie

Published in:

01-01-2013 | Letter to the editor

Should hyperthermia be included in the benefit catalogue for oncologic indications?

Commercial interests are presumed behind the editorial of R. Sauer et al.

Author: PD Dr. C. Wild

Published in: Strahlentherapie und Onkologie | Issue 1/2013

Excerpt

Sauer R, Creeze H, Hulshof M et al (2012) Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010. Strahlenther Onkol 188(3):209–215 …

R. Sauer and H. Crezee contributed equally to this manuscript.

Health Council of the Netherlands, Health Insurance of the Netherlands.

TARMED Suisse.

Sauer R, Creeze H, Hulshof M et al (2012) on behalf of the Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology. Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010”, Strahlenther Onkol:1–4

Mathis S, Johnasson T (2010) Hyperthermie. Decision Support Document 36 (2010); Ludwig Boltzmann Institut für Health Technology Assessment (LBI-HTA) ISSN-online: 1992–0496, available at http://eprints.hta.lbg.ac.at. Accessed 27 Jan 2012

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Medicine 6(7):e1000100 (http://www.plosmedicine.org)

Boutron I, Moher D, Altman DG et al (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295–309PubMed

Sharma S, Patel FD, Sandhu APS, Gupta BD, Yadav NS (1989) A prospective randomised study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5:151–159

Zee J van der, Gonzalez GD, Rhoon GC van et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355(9210):1119–1125PubMedCrossRef

Franckena M, Stalpers LJ, Koper PC et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70(4):1176–1182PubMedCrossRef

Harima Y, Nagata K, Harima K et al (2001) A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17(2):97–105PubMedCrossRef

Vasanthan A, Mitsumori M, Park JH et al (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 61(1):145–153PubMedCrossRef

10.

Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35(4):731–744PubMedCrossRef

11.

Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23(13):3079–3085PubMedCrossRef

12.

Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21(23):4270–4276PubMedCrossRef

13.

Issels RD, Lindner LH, Verweij J et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11(6):561–570PubMedCrossRef

14.

Lutgens L, Zee J van der, Pijls-Johannesma M et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev 3

15.

Colombo R, Salonia A, Leib Z et al (2011) Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 107(6):912–918PubMedCrossRef

Title: Should hyperthermia be included in the benefit catalogue for oncologic indications?
Commercial interests are presumed behind the editorial of R. Sauer et al.
Author: PD Dr. C. Wild
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 1/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0265-2

At a glance: The STEP trials

Springer Medicine

Should hyperthermia be included in the benefit catalogue for oncologic indications?

Commercial interests are presumed behind the editorial of R. Sauer et al.

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Influence of osteopontin silencing on survival and migration of lung cancer cells

Signifikante Verbesserung der lokalen Kontrolle bei Melanompatienten nach Lymphadenektomie und adjuvanter Strahlentherapie

Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques

Mitteilungen

Stereotactic ablative radiotherapy for small lung tumors with a moderate dose

Can treatment of pediatric Hodgkin’s lymphoma be improved by PET imaging and proton therapy?